Carl Zeiss Meditec AG’s (ETR:AFX) Share Price Matching Investor Opinion
Carl Zeiss Meditec AG’s (ETR:AFX) price-to-earnings (or “P/E”) ratio of 25.3x might make it look like a sell right now compared to the market in Germany, where around half of the companies have P/E ratios below 18x and even P/E’s below 10x are quite common. However, the P/E might be high for a reason and it requires further investigation to determine if it’s justified.
Carl Zeiss Meditec could be doing better as its earnings have been going backwards lately while most other companies have been seeing positive earnings…
